Geron Corp (NASDAQ:GERN)

3.48
Delayed Data
As of 4:00pm ET
 -0.11 / -3.06%
Today’s Change
1.74
Today|||52-Week Range
6.68
+93.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$621.4M

Company Description

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Contact Information

Geron Corp.
149 Commonwealth Drive
Menlo Park California 94025
P:(650) 473-7700
Investor Relations:

Employees

Shareholders

Individual stakeholders5.73%
Mutual fund holders24.97%
Other institutional11.78%

Top Executives

John A. ScarlettPresident, Chief Executive Officer & Director
Olivia K. BloomChief Financial Officer, Treasurer & Executive VP
Stephen N. RosenfieldSecretary, Executive VP & General Counsel
Melissa A. Kelly BehrsExecutive VP-Business Development & Portfolio
Andrew J. GrethleinExecutive VP-Development & Technical Operations